| 1 |
33435622 | Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers. | 2021 Jan 8 |
2 |
| 2 |
31853007 | PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma. | 2020 Mar |
3 |
| 3 |
33216839 | Evidence for functional and regulatory cross-talk between Wnt/β-catenin signalling and Mre11-Rad50-Nbs1 complex in the repair of cisplatin-induced DNA cross-links. | 2020 Nov 3 |
1 |
| 4 |
30638177 | Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair. | 2019 Mar |
1 |
| 5 |
26056972 | Expression of the Mre11-Rad50-Nbs1 complex in cisplatin nephrotoxicity. | 2015 Jul |
2 |
| 6 |
26514681 | Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity. | 2015 Dec 14 |
1 |
| 7 |
24415413 | Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele. | 2014 Feb |
2 |
| 8 |
20823140 | Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. | 2010 Sep 15 |
1 |
| 9 |
21063405 | Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer. | 2010 Dec 7 |
2 |
| 10 |
15467621 | Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer. | 2004 Oct |
5 |